• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CTI BioPharma Corp. - Common Stock (NQ: CTIC )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 23, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 9.090 (10)
    Ask (Size) 9.100 (186)
    Prev. Close 9.090
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 93,309,923
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival
    Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer. 
    Via Investor's Business Daily
    CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Performance

    More News

    Read More
    CTI BioPharma Corp. (NASDAQ: CTIC) Climbs to New 52-Week High
    Via Investor Brand Network
    Top 5 Health Care Stocks That Should Keep You Up At Night
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
    Via Benzinga
    The Latest Analyst Ratings for CTI BioPharma
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
    Via Benzinga
    CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Dow Falls 90 Points; Mesa Air Group Shares Plummet
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq, S&P 500 Higher As Bond Yields Retreat
    Via Talk Markets
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Syneos Health, Inc. (Nasdaq – SYNH), Franchise Group, Inc. (Nasdaq – FRG), CTI BioPharma Corp. (Nasdaq – CTIC), Ruth’s Inc. (Nasdaq – RUTH)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Microvast Holdings Shares Spike Higher
    Via Benzinga
    Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    CTI BioPharma Corp. (NASDAQ: CTIC) Near Top of Volume Charts in Wednesday Trading
    Via Investor Brand Network
    Why Shares of CTI BioPharma Are Soaring Wednesday
    Via The Motley Fool
    Nasdaq Surges Over 1%; US Inflation Falls In April
    Via Benzinga
    SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is SeaStar Medical (ICU) Stock Down 32% Today?
    Via InvestorPlace
    Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Why Is Babylon (BBLN) Stock Down 57% Today?
    Via InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.